RxDoctor Payments Data

Kelly Griffith-Bauer, MD

MOHS-Micrographic Surgery · Seattle, WANPI 1386905917

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Galderma Laboratories, L.p. accounts for 73.5% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for mohs-micrographic surgery clinicians in WA, where the typical reported total is $1,261.

$359in general payments, 2019–2025

Across 6 payments — averaging $59.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$264
  • AbbVie$95

What the payments were for

  • Food & beverage$359100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Galderma Laboratories, L.p.2$264
AbbVie(2 entities)4$95

How this compares

$359 in reported general payments places this provider in the 25th percentile of 38 mohs-micrographic surgery providers in Washington.

See all mohs-micrographic surgery providers in Washington

Medicare billing

Part B allowed, 2024
$568,033
Medicare patients
387
Services billed
1,219

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin19$141

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →